Literature DB >> 21429521

Pediatric dermatofibrosarcoma protuberans: multi-institutional outcomes.

Corey W Iqbal1, Shawn St Peter, Michael B Ishitani.   

Abstract

BACKGROUND: Dermatofibrosarcoma protuberans (DFSP) in children is uncommon.
METHODS: Retrospective review of patients ≤ 18 y with histopathologic diagnosis of DFSP from 1980-2010 treated at one of two tertiary referral centers.
RESULTS: Fifteen patients were treated for pathologically-confirmed DFSP (mean ± SE age 11.9 ± 1.3 y). There was a female preponderance: 12 females, 3 males. Follow-up was available in all patients over a median 5.8 y (range 0.2-20.1 y). Patients presented with subcutaneous nodule (n = 4), cutaneous plaque (n = 3), or red papule (n = 3); the description of the lesion was not available for five patients. Abdominal wall, lower extremity, and scalp were the most frequent sites involved (n = 4 each). Median time from onset of the lesion to pathologic diagnosis was 182 d (range 5-1, 114 d). All 15 patients underwent initial excisional biopsy, and the diagnosis of DFSP was made in 14. Thirteen patients then underwent re-excision (within a mean ± SE 20.4 ± 4.1 d) with negative margins. None of these patients had a recurrence. There were two recurrences: one with positive margins on excisional biopsy who did not have immediate re-excision; the other with a misdiagnosis on excisional biopsy. Both underwent re-excision with negative margins and have not had any further recurrence. No patients received adjuvant therapy. There were no disease-related deaths.
CONCLUSIONS: DFSP is a rare pediatric malignancy. Its presentation is variable, delaying diagnosis, which is made with excisional biopsy. Excision with clear margins is critical for cure.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21429521     DOI: 10.1016/j.jss.2011.01.042

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

Review 1.  Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities.

Authors:  Jennifer L Anderson; Christopher T Denny; William D Tap; Noah Federman
Journal:  Pediatr Res       Date:  2012-08       Impact factor: 3.756

Review 2.  Dermatofibrosarcoma Protuberans in Children.

Authors:  Aseel Sleiwah; Thomas C Wright; Thomas Chapman; Adam Dangoor; Francesca Maggiani; Rachel Clancy
Journal:  Curr Treat Options Oncol       Date:  2022-04-08

3.  Dermatofibrosarcoma protuberans in a 10-year-old child.

Authors:  Uwe Wollina
Journal:  J Dermatol Case Rep       Date:  2013-12-30

4.  Surgical Treatment of Enormous Recurrent Dermatofibrosarcoma Protuberans.

Authors:  Shijie Xing; Jianjun Wang; Wei Zhai; Tian Xia; Chuanxiao Wang
Journal:  Thorac Cardiovasc Surg Rep       Date:  2015-03-30

5.  Clinicopathological features of fibrosarcomatous dermatofibrosarcoma protuberans and the construction of a back-propagation neural network recognition model.

Authors:  Yanan Li; Jiaqi Liang; Xuewen Xu; Xian Jiang; Chuan Wang; Siyuan Chen; Bo Xiang; Yi Ji
Journal:  Orphanet J Rare Dis       Date:  2021-01-26       Impact factor: 4.123

6.  Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: 10 years' experience in a tertiary hospital.

Authors:  Chun-Hai Lo; Po-Man Tsang; Shui-Ying Cheng
Journal:  Autops Case Rep       Date:  2022-04-01

Review 7.  Update of pediatric soft tissue tumors with review of conventional MRI appearance-part 1: tumor-like lesions, adipocytic tumors, fibroblastic and myofibroblastic tumors, and perivascular tumors.

Authors:  Jack Porrino; Khalid Al-Dasuqi; Lina Irshaid; Annie Wang; Kimia Kani; Andrew Haims; Ezekiel Maloney
Journal:  Skeletal Radiol       Date:  2021-06-30       Impact factor: 2.199

8.  Dermatofibrosarcoma protuberans in a child: a case report.

Authors:  Prashant Goyal; Shelly Sehgal; Sompal Singh; Shalabh Rastogi
Journal:  Case Rep Dermatol Med       Date:  2012-12-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.